These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1106843)

  • 21. [Treatment of advanced digestive cancer with fluorouracil and methyl-CCNU].
    Fleischer I; Wainstein R; Jovtis S; Colombato LO
    Acta Gastroenterol Latinoam; 1978; 8(3):191-3. PubMed ID: 747086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II study of oral methyl-CCNU and prednisone in previously treated alkylating agent-resistant multiple myeloma.
    Tornyos K; Silberman H; Solomon A
    Cancer Treat Rep; 1977 Aug; 61(5):785-7. PubMed ID: 329977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methyl-CCNU versus methyl-CCNU and 5-fluorouracil in carcinoma of the large bowel.
    Posey LE; Morgan LR
    Cancer Treat Rep; 1977 Nov; 61(8):1453-8. PubMed ID: 922750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized trial of melphalan plus 5-fluorouracil (5-FU) versus methyl-CCNU plus 5-FU in patients with advanced colorectal cancer.
    Berman R; Giles GR; Malhotra A; Bird GG; Gajjar PD; Bunch GA; Hall R
    Cancer Treat Rep; 1978 Mar; 62(3):457-9. PubMed ID: 348316
    [No Abstract]   [Full Text] [Related]  

  • 25. Phase III comparison of the treatment of advanced gastrointestinal cancer with bolus weekly 5-FU vs. methyl-CCNU plus bolus weekly 5-FU. A Southwest Oncology Group study.
    Baker LH; Talley RW; Matter R; Lehane DE; Ruffner BW; Jones SE; Morrison FS; Stephens RL; Gehan EA; Vaitkevicius VK
    Cancer; 1976 Jul; 38(1):1-7. PubMed ID: 779949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iv methyl-CCNU, VM-26, and cranial irradiation in therapy for malignant brain tumors.
    Gutin PH; Walker MD
    Cancer Treat Rep; 1977 Dec; 61(9):1715-7. PubMed ID: 597821
    [No Abstract]   [Full Text] [Related]  

  • 27. Chemotherapy of gynecologic cancer with nitrosoureas: a randomized trial of CCNU and methyl-CCNU in cancers of the cervix, corpus, vagina, and vulva.
    Omura GA; Shingleton HM; Creasman WT; Blessing JA; Boronow RC
    Cancer Treat Rep; 1978 May; 62(5):833-5. PubMed ID: 350400
    [No Abstract]   [Full Text] [Related]  

  • 28. Unexpected pain syndrome during a phase I study of lv methyl-CCNU.
    Haas CD; Stephens RL; Leite CJ; Goodwin JW; Hoogstraten B
    Cancer Treat Rep; 1977 Oct; 61(7):1413-5. PubMed ID: 589605
    [No Abstract]   [Full Text] [Related]  

  • 29. Chronic renal failure in children treated with methyl CCNU.
    Harmon WE; Cohen HJ; Schneeberger EE; Grupe WE
    N Engl J Med; 1979 May; 300(21):1200-3. PubMed ID: 431647
    [No Abstract]   [Full Text] [Related]  

  • 30. Iv methyl-CCNU and ftorafur with or without methanol-extracted residue of BCG for metastatic adenocarcinoma of the colon.
    Diggs CH; Wiernik PH; Smyth AC
    Cancer Treat Rep; 1977 Nov; 61(8):1581-3. PubMed ID: 336200
    [No Abstract]   [Full Text] [Related]  

  • 31. Combination chemotherapy with adriamycin (NSC-123127) and 1-(2-chloroethyl)-3-cyclohexyl 1-nitrosourea (CCNU; NSC-79037).
    Einhorn LH; Livingston RB; Gottlieb JA
    Cancer Chemother Rep; 1973; 57(4):437-45. PubMed ID: 4586951
    [No Abstract]   [Full Text] [Related]  

  • 32. Case report: acute leukemia after semustine (methyl-CCNU) therapy.
    Uphouse WJ; Oishi N
    Cancer Treat Rep; 1982 Jul; 66(7):1593-4. PubMed ID: 6953997
    [No Abstract]   [Full Text] [Related]  

  • 33. Combination chemotherapy with cyclophosphamide, vincristine, methyl-CCNU, and bleomycin in advanced bronchogenic carcinoma: experience with 106 patients.
    Samson MK; Baker LH; Fraile RJ; Izbicki RM; Vaitkevicius VK
    Cancer Treat Rep; 1977; 61(1):59-64. PubMed ID: 67895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase II study of intravenously- administered methyl CCNU in the treatment of advanced sarcomas.
    Chang P; Levine MA; Wiernik PH; Walker MD
    Cancer; 1976 Feb; 37(2):615-9. PubMed ID: 766946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of methyl-CCNU and procarbazine in advanced malignant melanoma resistant to DTIC therapy.
    Didolkar MS; Baffi RR; Catane R; Kaufman J; Holyoke ED
    Cancer Treat Rep; 1977 Dec; 61(9):1738-9. PubMed ID: 597824
    [No Abstract]   [Full Text] [Related]  

  • 36. [Use of nitrosourea compounds in cancer chemotherapy].
    Robak T
    Pol Tyg Lek; 1982 Sep; 37(36):1067-70. PubMed ID: 6763214
    [No Abstract]   [Full Text] [Related]  

  • 37. Adjuvant nitrosourea therapy for glioblastoma.
    Brisman R; Housepian EM; Chang C; Duffy P; Balis E
    Arch Neurol; 1976 Nov; 33(11):745-50. PubMed ID: 985152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical studies in malignant gliomas and their treatment with the nitrosoureas.
    Walker MD; Gehan EA
    Cancer Treat Rep; 1976 Jun; 60(6):713-6. PubMed ID: 782695
    [No Abstract]   [Full Text] [Related]  

  • 39. 5-Fluorouracil (5-FU), methyl-CCNU, and vincristine in the treatment of advanced colorectal cancer: phase II study utilizing weekly 5-FU.
    Macdonald JS; Kisner DF; Smythe T; Woolley PV; Smith L; Schein PS
    Cancer Treat Rep; 1976 Nov; 60(11):1597-600. PubMed ID: 1021233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nitrosoureas: a reappraisal of clinical trials.
    Katz ME; Glick JH
    Cancer Clin Trials; 1979; 2(4):297-316. PubMed ID: 394866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.